Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Measurement of the Distribution of Optical Properties in Adult Human Muscle

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00540683
Recruitment Status : Withdrawn (Not NIH defined clinical trials.)
First Posted : October 8, 2007
Last Update Posted : April 18, 2018
Sponsor:
Collaborator:
Beckman Laser Institute University of California Irvine
Information provided by (Responsible Party):
Beckman Laser Institute and Medical Center, University of California, Irvine

Tracking Information
First Submitted Date October 4, 2007
First Posted Date October 8, 2007
Last Update Posted Date April 18, 2018
Study Start Date October 2004
Estimated Primary Completion Date July 2018   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: November 6, 2014)
Healthy Muscle [ Time Frame: upto 4 weeks ]
Original Primary Outcome Measures Not Provided
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Measurement of the Distribution of Optical Properties in Adult Human Muscle
Official Title Measurement of the Distribution of Optical Properties in Adult Human Muscle
Brief Summary The researcher can use Diffuse Optical spectroscopy technique that uses harmless levels of near-infrared light to probe the concentrations and states of important physiological molecules such as hemoglobin water and lipids in human muscle,.
Detailed Description

The researcher can monitor muscle physiology, for example during exercise or in response to external factors such as shock by Diffuse Optical spectroscopy technique.

The Diffuse Optical spectroscopy technique can determine significant changes in muscle, muscle structure, muscle tissues metabolism and hemodynamics.

Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Study population will be selected from outpatient clinic at University Of California Irvine, and staffs and students.
Condition Muscle Disorder
Intervention Device: Diffuse Optical Spectroscopy
Muscle properties
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Withdrawn
Actual Enrollment
 (submitted: April 16, 2018)
0
Original Estimated Enrollment
 (submitted: October 4, 2007)
140
Estimated Study Completion Date July 2018
Estimated Primary Completion Date July 2018   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Male or Female age 18 years and older
  • Diagnosed of Cachexic condition
  • Diagnosed of Cellulite adult female 18 years and older

Exclusion Criteria:

  • Pregnant women
  • Taking light sensitive drugs for use in photodynamic therapy
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 75 Years   (Adult, Older Adult)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries United States
Removed Location Countries  
 
Administrative Information
NCT Number NCT00540683
Other Study ID Numbers NIH/LAMMP-2004-3626
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Beckman Laser Institute and Medical Center, University of California, Irvine
Study Sponsor University of California, Irvine
Collaborators Beckman Laser Institute University of California Irvine
Investigators
Principal Investigator: Bruce Tromberg, Ph.D Beckman Laser Institute University of California Irvine
PRS Account University of California, Irvine
Verification Date April 2018